BTAIVSNNNN• 28 Days (Normalized)
BTAI vs NNNN (BioXcel Therapeutics Inc. vs Anbio Biotechnology)
Showing Closing Date Range from Aug, 14 to Sep, 11, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
BTAI Performance $0.05
-95.71%
BioXcel Therapeutics Inc.
Normalized Baseline0.00%
NNNN Performance $6.34
-27.46%
Anbio Biotechnology
Normalized Baseline0.00%
Alpha Spread Margin NNNN LEADS
-68.25%
NNNN outperforming by 68.25%
BTAINNNN
Spread Trajectory28 Days (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
BTAI NNNN
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(20 dates)
| Date | BTAI Price | BTAI Gain (%) | NNNN Price | NNNN Gain (%) | Spread |
|---|---|---|---|---|---|
| Sep 11, 2026 | $0.05 | -95.71% | $6.34 | -27.46% | -68.25% |
| Sep 10, 2026 | $0.05 | -95.80% | $6.51 | -25.51% | -70.29% |
| Sep 09, 2026 | $0.05 | -96.05% | $6.47 | -25.97% | -70.08% |
| Sep 08, 2026 | $0.04 | -96.39% | $6.48 | -25.86% | -70.53% |
| Sep 04, 2026 | $0.07 | -93.78% | $6.54 | -25.17% | -68.61% |
| Sep 03, 2026 | $0.12 | -90.08% | $6.60 | -24.49% | -65.59% |
| Sep 02, 2026 | $0.11 | -91.01% | $6.85 | -21.62% | -69.39% |
| Sep 01, 2026 | $0.14 | -88.49% | $7.22 | -17.39% | -71.10% |
| Aug 31, 2026 | $0.16 | -86.30% | $7.30 | -16.48% | -69.82% |
| Aug 28, 2026 | $0.18 | -84.79% | $7.67 | -12.24% | -72.55% |
| Aug 27, 2026 | $0.72 | -39.58% | $7.78 | -10.98% | -28.60% |
| Aug 26, 2026 | $0.78 | -34.45% | $7.72 | -11.67% | -22.78% |
| Aug 25, 2026 | $0.74 | -37.65% | $7.83 | -10.41% | -27.24% |
| Aug 24, 2026 | $0.76 | -36.05% | $7.90 | -9.61% | -26.44% |
| Aug 21, 2026 | $0.80 | -32.44% | $6.81 | -22.08% | -10.36% |
Page 1 of 2